Quoin Pharmaceuticals, Ltd.Quoin Pharmaceuticals, Ltd.Quoin Pharmaceuticals, Ltd.

Quoin Pharmaceuticals, Ltd.

No trades
See on Supercharts
Market capitalization
‪710.80 K‬USD
−8.7946USD
‪−8.66 M‬USD
Beta (1Y)
1.92

About Quoin Pharmaceuticals, Ltd.

CEO
Michael Myers
Headquarters
Ashburn
Employees (FY)
4
Founded
2018
ISIN
US74907L3006
FIGI
BBG00D9PB2L6
Quoin Pharmaceuticals Ltd. engages in the development of therapeutic products for the treatment of rare and orphan diseases. Its product pipeline includes QRX003, QRX004, QRX007, and QRX008. The company was founded by Michael Myers and Denise Carter on March 5, 2018 and is headquartered in Ashburn, VA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.